Shopping Cart
Remove All
Your shopping cart is currently empty
Sacituzumab govitecan (Alias: IMMU-132)
Catalog No. T77824 Copy Product Info
Purity: 95%
🥰Excellent
Sacituzumab govitecan (IMMU-132) is a humanized ADC compound targeting Trop-2 with anticancer activity for the study of refractory, locally advanced or metastatic breast cancer and uroepithelial cancer.
Sacituzumab govitecan
Copy Product Info🥰Excellent
Catalog No. T77824
Alias IMMU-132
Sacituzumab govitecan (IMMU-132) is a humanized ADC compound targeting Trop-2 with anticancer activity for the study of refractory, locally advanced or metastatic breast cancer and uroepithelial cancer.
Sacituzumab govitecan
Cas No. 1491917-83-9
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $455 | In Stock | In Stock | |
| 5 mg | $1,360 | - | In Stock | |
| 10 mg | $1,830 | - | In Stock | |
| 25 mg | $2,730 | - | In Stock |
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:98.4% (SEC-HPLC)
Appearance:Liquid
Color:Transparent to Yellow
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Sacituzumab govitecan (IMMU-132) is a humanized ADC compound targeting Trop-2 with anticancer activity for the study of refractory, locally advanced or metastatic breast cancer and uroepithelial cancer. |
| In vivo | Sacituzumab govitecan administered at a dose of 17.5 mg/kg twice weekly for four consecutive weeks showed significant antitumor effects in mice bearing human gastric cancer xenograft tumors. [1] |
| Synonyms | IMMU-132 |
| Reactivity | Human |
| Verified Activity | Immobilized Human TROP2 Protein (ECD, His) at 2 μg/mL (30 μL/well) can bind Sacituzumab govitecan. The EC50 is 0.005813 μg/mL.  |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | TROP-2 |
| Molecular Weight | 160 KDa (Approximately) |
| Cas No. | 1491917-83-9 |
| Isotype | IgG1 |
| Storage | store at low temperature | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O: 20 mg/mL, Sonication is recommended. |
Calculator
Keywords
Preview
Related Tags: buy Sacituzumab govitecan | purchase Sacituzumab govitecan | Sacituzumab govitecan cost | order Sacituzumab govitecan | Sacituzumab govitecan in vivo | Sacituzumab govitecan molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.